Loading company…
Verax Biomedical develops tests to detect bacterial contamination in blood products, particularly platelets.
Verax Biomedical develops diagnostic tests for bacterial contamination in blood products, particularly platelets. Its Platelet PGD Test uses PGDprime technology for rapid detection, including Acinetobacter species. Founded in 1999, the company is based in Marlborough, US and serves hospitals, blood banks, and healthcare providers. In September 2019, it raised USD 2.54 mn in venture debt financing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in